Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1574 of 6351
-
New pill aims to ease burning nerve pain in diabetes
Symptom relief Not yet recruitingThis is a multi-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for diabetic peripheral neuropathic pain.
Phase 2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 14:42 UTC
-
New male birth control pill enters human testing
Disease control Not yet recruitingIn all, 200 healthy, sexually active, fertile male candidates will be assigned 100 in silodosin group and 100 in placebo group. Males using other contraceptive methods will be excluded. Follow up data of total spermatozoa per ejaculate, semen volume and Post-ejaculation urinalysi…
Phase 1 • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New eye drop combo could save sight from fungal infections
Disease control Recruiting nowThe goal of this clinical trial is to learn if adjunctive topical Cyclosporine A eye drops combined with standard of care topical Natamycin treatment improves vision outcomes in patients with fungal keratitis.
Phase 3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug aims to shield cancer patients from chemo side effects
Disease control Not yet recruitingEvaluate the efficacy and safety of Trilaciclib for myeloprotection prior to chemotherapy in advanced cholangiocarcinoma or pancreatic cancer.
Phase 2 • Sponsor: The Second Affiliated Hospital of Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:31 UTC
-
New drug cocktail aims to slow kidney disease in IgA patients
Disease control Recruiting nowApplication of Budesonide in Combination with Ambrisentan in the treatment of IgA nephropathy with progression ESKD risk (24-hour urinary protein ≥ 0.5g/24h), observing the degree and safety of reducing urinary protein and delaying eGFR progression, and observing changes in serum…
Phase 4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
New malaria vaccine vivaxin enters first human tests
Vaccine Not yet recruitingPhase 1 clinical trial to evaluate the safety, reactogenicity, and immunogenicity of a malaria vaccine named Vivaxin against the protozoan Plamodium vivax in participants with no prior malaria infection
Phase 1 • Sponsor: Federal University of Minas Gerais • Aim: Vaccine
Last updated Jun 26, 2026 17:21 UTC
-
Could 2 years of hormone therapy be enough for some breast cancers?
Disease control Not yet recruitingThis study is a prospective, randomized, open-label, non-inferiority Phase III clinical trial, planning to enroll 2,934 patients, with a 1:1 allocation to either the conventional endocrine therapy group or the de-escalation therapy group. The aim is to evaluate the safety and eff…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis is an investigator-initiated trial to evaluate the efficacy and safety of BCMA/CD70-targeted CAR-T in the treatment of refractory pediatric rheumatic diseases.
Phase 1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
New psoriasis pill enters Mid-Stage trial
Disease control Not yet recruitingThe primary objective of this study is to evaluate the efficacy of multiple-dose HSK47388 versus placebo in participants with moderate-to-severe plaque psoriasis.
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:49 UTC
-
New hope for liver cancer: drug targets tumors resistant to immunotherapy
Disease control Not yet recruiting1. To investigate the efficacy and safety of cabozantinib in patients with progressive HCC after ICI-based combination treatment. 2. To explore potential tissue and peripheral blood biomarkers associated with clinical benefits of cabozantinib, and resistance mechanisms of prior I…
Phase 2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
New hope for rare blood disorder: linprixel trial launches
Disease control Not yet recruitingwAIHA or EVANS syndrome: Linpriril 40mg, oral, once daily. The therapeutic effect will be evaluated after 4 weeks. If the therapeutic effect does not reach the PR, the dose will be increased to 60mg once a day. After continuing to take it for 4 weeks, the therapeutic effect will …
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowAt present, no cell drug with an indication for mCRPC has been approved for marketing in China, and there is no scholar to fight against it PSMA-CAR-NK cell therapy CRPC was reported in a study. Based on the previous basic research, our company has developed CAR-NK cell injection…
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New wearable could spot lung fluid before symptoms worsen
Diagnosis Recruiting nowThis study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techni…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Custom stent grafts offer new hope for High-Risk aneurysm patients
Disease control Recruiting nowThis single-arm FDA-monitored protocol intends to broaden endovascular device applicability using physician-modifications in patients who A) Have anatomical conditions not amenable to endovascular repair using currently marketed grafts in the United States. B) Are at high risk fo…
Sponsor: Steven Maximus • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to catch heart risks early in cancer treatment
Knowledge-focused Recruiting nowThis study will prospectively monitor cancer patients receiving chemotherapy (including molecular targeted therapies) for cardiovascular adverse events using biomarkers and imaging. The goal is to develop a predictive model for major adverse cardiovascular events (MACE) in this p…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New allergy tablet could help millions breathe easier
Symptom relief OngoingA research study of house dust mite (HDM) SLIT-tablet for the treatment of HDM allergy in Chinese participants aged 12-65.
Phase 3 • Sponsor: ALK-Abelló A/S • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New combo therapy may help spina bifida kids stay dry
Disease control CompletedBackground: Overactive bladder and urinary incontinence in children have significant influence on psychosocial well-being and quality of life. The current study compared the effectiveness of the Multimodal Intervention (MMI) protocol to a Conventional Intervention (CI) in increas…
Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a new type of therapy help people with PTSD?
Symptom relief Recruiting nowThis study is a longitudinal, multicenter, single-blind, two-arm randomized controlled trial designed to evaluate the effectiveness of Multi-Modal Cognitive Processing Therapy (MMCPT) for individuals with posttraumatic stress disorder (PTSD). Participants will be randomly assigne…
Sponsor: Far Eastern Memorial Hospital • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can a health coach ease the burden of pancreatic cancer?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a community health worker led intervention that helps facilitate palliative care works to treat newly-diagnostic pancreatic cancer. It will also help understand the impact of this intervention on people who are caregivers for patient…
Sponsor: Loma Linda University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
A simple blood test may reveal how ewing sarcoma responds to therapy
Knowledge-focused Recruiting nowThis single-center prospective observational study aims to evaluate whether longitudinal changes in serum pro-gastrin-releasing peptide (ProGRP) reflect treatment response in patients with newly diagnosed Ewing sarcoma. Serum ProGRP levels will be measured before systemic treatme…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC